Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Zerko Wako, Daniel Mengistu, Negalign Getahun Dinegde, Tseganesh Asefa & Mulugeta Wassie. (2021) Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer Attending the Tikur Anbessa Specialized Hospital, Addis Ababa Ethiopia, 2019: A Cross-sectional Study. Breast Cancer: Targets and Therapy 13, pages 383-392.
Read now
Read now
Yolanda Eraso. (2019) Oncologists’ perspectives on adherence/non-adherence to adjuvant endocrine therapy and management strategies in women with breast cancer. Patient Preference and Adherence 13, pages 1311-1323.
Read now
Read now
Zoe Moon, Rona Moss-Morris, Myra S Hunter, Sophie Carlisle & Lyndsay D Hughes. (2017) Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review. Patient Preference and Adherence 11, pages 305-322.
Read now
Read now
Articles from other publishers (14)
Samuel G Smith, Sophie M C Green, Rachel Ellison, Robbie Foy, Christopher D Graham, Ellen Mason, David P French, Louise H Hall, Hollie Wilkes, Emma McNaught, Erin Raine, Rebecca Walwyn, Daniel Howdon, Jane Clark, Nikki Rousseau, Jacqueline Buxton, Sally J L Moore, Catherine Parbutt, Galina Velikova, Amanda Farrin & Michelle Collinson. (2023) Refining and optimising a behavioural intervention to support endocrine therapy adherence (ROSETA) in UK women with breast cancer: protocol for a pilot fractional factorial trial. BMJ Open 13:2, pages e069971.
Crossref
Crossref
Beomyoung Cho, Maria Pérez, Donna B. Jeffe, Matthew W. Kreuter, Julie A. Margenthaler, Graham A. Colditz & Ying Liu. (2022) Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer. BMC Cancer 22:1.
Crossref
Crossref
Louise H. Hall, Natalie V. King, Christopher D. Graham, Sophie M. C. Green, Alice Barber, Richard D. Neal, Robbie Foy, Jane Clark, Kelly E. Lloyd & Samuel G. Smith. (2021) Strategies to self-manage side-effects of adjuvant endocrine therapy among breast cancer survivors: an umbrella review of empirical evidence and clinical guidelines. Journal of Cancer Survivorship 16:6, pages 1296-1338.
Crossref
Crossref
Erin J. Aiello Bowles, Cody Ramin, Diana S. M. Buist, Heather Spencer Feigelson, Sheila Weinmann, Lene H. S. Veiga, Clara Bodelon, Rochelle E. Curtis, Jacqueline B. Vo, Amy Berrington de Gonzalez & Gretchen L. Gierach. (2022) Endocrine therapy initiation among women with stage I–III invasive, hormone receptor-positive breast cancer from 2001–2016. Breast Cancer Research and Treatment 193:1, pages 203-216.
Crossref
Crossref
Katherine E. Reeder-Hayes, Melissa A. Troester & Stephanie B. Wheeler. (2021) Adherence to Endocrine Therapy and Racial Outcome Disparities in Breast Cancer. The Oncologist 26:11, pages 910-915.
Crossref
Crossref
Cynthia Villarreal-Garza, Fernanda Mesa-Chavez, Ana S. Ferrigno, Cynthia De la Garza-Ramos, Alan Fonseca, Karen Villanueva-Tamez, Jose Y. Campos-Salgado, Marlid Cruz-Ramos, David O. Rodriguez-Gomez, Sandy Ruiz-Cruz & Paula Cabrera-Galeana. (2021) Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico. The Breast 59, pages 8-15.
Crossref
Crossref
Leah K. Lambert, Lynda G. Balneaves, A. Fuchsia Howard, Stephen L. K. Chia & Carolyn C. Gotay. (2021) Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer. Current Oncology 28:2, pages 1472-1482.
Crossref
Crossref
Maurice J. Berkowitz, Carlie K. Thompson, Laura T. Zibecchi, Minna K. Lee, Elani Streja, Jacob S. Berkowitz, Cachet M. Wenziger, Jennifer L. Baker, Maggie L. DiNome & Deanna J. Attai. (2020) How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support. Journal of Cancer Survivorship 15:1, pages 29-39.
Crossref
Crossref
Jennifer C. Spencer, Bryce B. Reeve, Melissa A. Troester & Stephanie B. Wheeler. (2020) Factors Associated with Endocrine Therapy Non‐Adherence in Breast Cancer Survivors. Psycho-Oncology 29:4, pages 647-654.
Crossref
Crossref
Julie S Bedi, Rachel M Mayo, Liwei Chen, Lori Dickes, Windsor W Sherrill & Karyn Jones. (2019) Factors associated with longer endocrine therapy use by South Carolina Medicaid-insured breast cancer survivors. Journal of Oncology Pharmacy Practice 26:1, pages 36-42.
Crossref
Crossref
Anne Lesur, Florence Dalenc & Marie Beguignot. (2019) Consultation dédiée de prescription d’une hormonothérapie adjuvante chez la femme jeune traitée pour cancer du sein hormonosensible : une clé pour améliorer l’adhésion ?. Bulletin du Cancer 106:12, pages S28-S36.
Crossref
Crossref
Kari Britt Hagen, Turid Aas, Jan Terje Kvaløy, Håvard Søiland & Ragna Lind. (2019) Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: A 5-year prospective study. The Breast 44, pages 52-58.
Crossref
Crossref
Rutugandha Paranjpe, Grace John, Meghana Trivedi & Susan Abughosh. (2018) Identifying adherence barriers to oral endocrine therapy among breast cancer survivors. Breast Cancer Research and Treatment 174:2, pages 297-305.
Crossref
Crossref
Yiqi Pan, Sarah R. Heisig, Pia von Blanckenburg, Ute-Susann Albert, Peyman Hadji, Winfried Rief & Yvonne Nestoriuc. (2018) Facilitating adherence to endocrine therapy in breast cancer: stability and predictive power of treatment expectations in a 2-year prospective study. Breast Cancer Research and Treatment 168:3, pages 667-677.
Crossref
Crossref